Allermi, a San Francisco, CA-based direct-to-consumer telehealth service, raised $3.5M in Seed funding.
The spherical was led by Nelstone Ventures, and FourSight Capital Companions.
The corporate intends to make use of the funds to proceed nationwide growth; construct and scale enterprise, advertising and product operations; and enlarge advertising channels.
Led by CEO Shani Bocian, Allermi is a direct-to-consumer telehealth service offering a personalized method to allergy aid.
Dr. Robert Bocian is an allergist for greater than 30 years, affiliate professor of allergy-immunology at Stanford and inventor of Bocian’s Potions, the customized method provided by Allermi that mixes and adjusts the doses of a number of clinically-proven medicines into one nasal spray bottle to handle sufferers’ particular signs.
After finishing a web based questionnaire that’s then evaluated by an Allermi doctor, sufferers are prescribed a personalized nasal spray containing as much as 4 lively treatment components, mixed and dosed for every affected person’s distinctive signs and severity.
Delivered by mail on a month-to-month or on-demand foundation, every affected person receives a personalised therapy plan, together with entry to a devoted care group which sufferers can contact for ongoing help.
Allermi is at the moment accessible to residents 18 or older in 28 states together with: Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Vermont and Washington.
Leave a Reply